IC
PMN icon

IEQ Capital’s ProMIS Neurosciences PMN Stock Holding History

IEQ Capital’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,042
Closed -$11.1K – 1967
2025
Q3 		$11.1K Hold
1,042
– – ﹤0.01% 1828
2025
Q2 		$12.6K Hold
1,042
– – ﹤0.01% 1803
2025
Q1 		$18.1K Hold
1,042
– – ﹤0.01% 1587
2024
Q4 		$24.7K Hold
1,042
– – ﹤0.01% 1316
2024
Q3 		$32.6K Hold
1,042
– – ﹤0.01% 1141
2024
Q2 		$39.1K Hold
1,042
– – ﹤0.01% 982
2024
Q1 		$49.7K Sell
1,042
-190
-15% -$9.4K ﹤0.01% 948
2023
Q4 		$35.4K Sell
1,232
-336
-21% -$12.6K ﹤0.01% 916
2023
Q3 		$77.6K Hold
1,568
– – ﹤0.01% 901
2023
Q2 		$152K Hold
1,568
– – ﹤0.01% 822
2023
Q1 		$185K Hold
1,568
– – ﹤0.01% 828
2022
Q4 		$170K Hold
1,568
– – ﹤0.01% 751
2022
Q3 		$240K Buy
+1,568
New +$231K 0.01% 724

Other funds holding PMN

ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DEM
Disciplined Equity Management Neptune Beach, Florida $226M AUM 27.21% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

IEQ Capital's PMN Position: Q4 2025 in Review

IEQ Capital sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 1,042 shares — an estimated $11.1K sold.

IEQ Capital first reported a position in PMN in Q3 2022 and held it in 13 quarters. The position peaked at $240K in Q3 2022. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

  • IEQ Capital reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
  • IEQ Capital sold 1,042 ProMIS Neurosciences shares in Q4 2025, an estimated $11.1K.
  • IEQ Capital first reported a position in ProMIS Neurosciences in Q3 2022 and held it in 13 quarters.
  • IEQ Capital's ProMIS Neurosciences position peaked at $240K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on IEQ Capital's 13F filing for Q4 2025, filed 13 Feb 2026.